Riskpilot← Back to searchSign inGet full accessKLINIKK24 AS
ASActiveOrg 998729955Strandvegen 106, 9006 TromsøPhysiotherapy activities · NACE 8695Est. 20120 employeeswww.klinikk24.no
Revenue 2024
NOK 1,1M
-49% vs 2023
EBITDA margin
20.9%
+163% vs 2023
Equity ratio
-409.2%
Financial strength
Net profit 2024
NOK 170K
+147% vs 2023
| Revenue | NOK 1,1M | -49% |
| EBITDA | NOK 227K | +163% |
| Net profit | NOK 170K | +147% |
| Total assets | NOK 231K | -3% |
| Equity | NOK -944K | +15% |
| Employees | 0 | — |
Legal name
KLINIKK24 AS
Org number
998729955
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
20. august 2012
Share capital
NOK 870 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Levering av helsetjenester manuellterapi, fysioterapi, massasje.
Address
Strandvegen 106, 9006 Tromsø
Website
www.klinikk24.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 53 | 468 | 757 | 3 596 | 4 274 | 5 331 | 4 600 | 4 418 | 4 094 | 3 662 | 2 795 | 2 124 | 1 088 |
| Staff expenses | −0 | −0 | −10 | −10 | −3 | −47 | −0 | −22 | −241 | −287 | −260 | −121 | −2 |
| EBITDA | −99 | 122 | 148 | 326 | 296 | 145 | −489 | 4 | −298 | 197 | 86 | −362 | 227 |
| Depreciation & amort. | −0 | −10 | −13 | −22 | −0 | −494 | −317 | −317 | −317 | −185 | −0 | −0 | −0 |
| EBIT | −99 | 111 | 134 | 304 | 296 | −350 | −805 | −313 | −615 | 13 | 86 | −362 | 227 |
| Net financials | −8 | −14 | −10 | −7 | −14 | −69 | −46 | −39 | −29 | −11 | −6 | 0 | −57 |
| Profit before tax | −108 | 98 | 124 | 296 | 282 | −419 | −851 | −352 | −644 | 2 | 80 | −362 | 170 |
| Tax | −0 | −0 | 46 | 80 | −14 | 6 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −108 | 98 | 78 | 216 | 296 | −425 | −851 | −352 | −644 | 2 | 80 | −362 | 170 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 113 | 177 | 298 | 480 | 1 885 | 1 981 | 1 329 | 938 | 695 | 817 | 893 | 238 | 231 |
| Equity | −80 | 18 | 96 | 312 | 608 | 183 | −668 | −1 020 | −834 | −832 | −752 | −1 114 | −944 |
| Long-term debt | 192 | 142 | 104 | 49 | 1 334 | 971 | 718 | 595 | 299 | 60 | 60 | 60 | 60 |
| Short-term debt | 1 | 18 | 98 | 119 | −57 | 828 | 1 280 | 1 364 | 1 230 | 1 589 | 1 585 | 1 292 | 1 114 |
| Total debt | 193 | 159 | 202 | 168 | 1 277 | 1 798 | 1 997 | 1 958 | 1 529 | 1 649 | 1 645 | 1 352 | 1 174 |
EBITDA margin
20.9%
This company
15.8%
Market median
+32% vs market
20122024
Equity ratio
-409.2%
This company
38.2%
Market median
-1171% vs market
20122024
Return on equity
17001200.0%
This company
18.4%
Market median
+92397726% vs market
20122024
Net profit margin
15.6%
This company
8.1%
Market median
+93% vs market
20122024
Asset turnover
4.72×
This company
1.12×
Market median
+321% vs market
20122024
Debt / equity
1.24×
This company
0.62×
Market median
-100% vs market
20122024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KE Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2012 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Clavicula As | Company | 38.2% | 38.2% | 2022 |
Pelto Invest As | Company | 38.2% | 38.2% | 2022 |
| Individual | 20.0% | 20.0% | 2022 | |
| Individual | 1.4% | 1.4% | 2022 | |
| Individual | 1.4% | 1.4% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KLINIKK24 AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristin Evensen | Chief Executive Officer | 0 companies |
| Einar Lomås Hauglid | Board of Directors | 0 companies |
| Tord Morten Peltoperæ Moen | Board of Directors | 0 companies |